Publications by authors named "Natalia K A Maverakis"
Front Med (Lausanne)
February 2023
Article Synopsis
- Mutations in melanoma are common and associated with a poorer prognosis, but their influence on the effectiveness of immune checkpoint inhibitors (ICIs) is still unclear.
- A comprehensive literature review analyzed studies of patients with melanoma to determine the objective response rate (ORR) to ICIs based on mutational status.
- The results showed that -mutant melanoma had a higher likelihood of responding to ICIs compared to -wildtype melanoma, suggesting that genomic screening could help predict better treatment outcomes.
